Along with an increase in the percentage of CD8+ T cells, cancer patients also had 170% higher levels of PD-L1+CD8+ T cells (p=0.0025, Figure 5B) and 165% higher levels of CTLA-4+CD8+ T cells (p=0.0025, Figure 5C). The gene discussed is CD274; the disease is cancer.